BRANDI SAMSON: Open Payments
NPI 1457850497 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,773 in 82 payments from 32 companies in 2025. Trend: 2023 $1,592 · 2024 $614 · 2025 $1,773
Food & beverage: $1,574Education: $199
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $290 |
| ABBVIE INC. | 10 | $168 |
| PFIZER INC. | 10 | $128 |
| SEAGEN INC. | 1 | $99 |
| Merck Sharp & Dohme LLC | 4 | $97 |
| Daiichi Sankyo Inc. | 4 | $84 |
| GENZYME CORPORATION | 4 | $83 |
| GlaxoSmithKline, LLC. | 3 | $66 |
| AstraZeneca Pharmaceuticals LP | 3 | $60 |
| Aveo Pharmaceuticals, Inc. | 2 | $59 |
Products named: ERLEADA, KEYTRUDA, DARZALEX, Enhertu, IBRANCE, FOTIVDA, SARCLISA, OPDIVO.
Industry payments across MO — which companies pay providers there.
